viewSmart Metering Systems PLC

Smart Metering Systems faces “little risk” from meter removal says Barclays as it upgrades

The bank said there was “little risk” of early removal of meters following several incidents in 2018 when SMETS1 meters went ‘dumb’ after switching suppliers

SMS logo on glass door
Barclays did also cut their target price to 545p from 650p, citing “uncertainty” over the asset life of SMS meters

The risk of early removals of energy meters supplied by Smart Metering Systems PLC (LON:SMS) is “overplayed” according to Barclays, which on Monday upgraded its rating on the stock.

Barclays said that there was “little risk” of further early removal of meters following several “freak” incidents in 2018 when some of the company’s SMETS1 meters went ‘dumb’ when customers switched energy suppliers.

Analysts at the bank said these removals were “unique”, that utility firms “do not really benefit” from removals and that all meters now communicate with a central network irrespective of the consumers’ utility provider.

SMS has “some protection” against removals, which could in fact drive upside to revenues as utility firms not providing termination protection could pay higher rents on the meters.

However, while Barclays upgraded to ‘overweight’ from ‘equal weight’, the share price target was slashed to 545p from 650p, citing “uncertainty” over the asset life of SMS meters, highlighting that the company’s meters had a depreciation of around 20 years while traditional meters were around 40 years.

Despite this, Barclays remained positive, saying that the firm’s expected annualised recurring revenues (ARR) of £85.9mln for the first half of 2019 were “undervalued” with the further roll-out of meters and potential disposals potentially serving as a “catalyst to unlock value”.

In lunchtime trading on Monday, SMS shares were 1.4% higher at 459.2p.

Quick facts: Smart Metering Systems PLC

Price: 507.5 GBX

Market: AIM
Market Cap: £572.42 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Full interview: Polarean Imaging achieves positive phase III results in two...

Polarean Imaging PLC (LON:POLX) CEO Richard Hullihen tells Proactive its two phase III clinical trials have 'demonstrated handily' that its technology allows doctors and surgeons to visualize aspects of lung function that have gone undetected using traditional magnetic resonances imaging (MRI)...

55 minutes ago

2 min read